Germany has taken a historic step by permitting psychiatrists to prescribe psilocybin for treatment‑resistant depression under a compassionate‑use framework. This marks the first time a European Union country has given doctors authority to administer the psychedelic compound outside of clinical trials. The Central Institute of Mental Health (CIMH) in Mannheim and Berlin’s OVID Clinic, both...
The 2018 Farm Bill, formally known as the Agriculture Improvement Act of 2018, marked a pivotal moment in the history of cannabis legislation in the United States. Among its broad-ranging provisions, the bill federally legalized hemp, a variety of the Cannabis sativa plant species, and its derivatives, thus distinguishing them from their psychoactive cousin, marijuana....
In the rapidly expanding cannabis market, THCa flower has emerged as both a hot trend and a legal gray area. Touted as “hemp” under the 2018 Farm Bill, THCa products offer effects nearly identical to traditional marijuana when smoked or vaped, while technically remaining legal in some states. But with popularity comes confusion—and potential risks. Whether...
With “psychedelics” headlining articles left and right, and “harm reduction” turning into a household name, this year is bound to be a revolutionary time for advancements and policy changes in the drug space. Even the U.S. government is jumping on board, with a budget of $509.4 million specifically dedicated to harm reduction efforts—up 26%...
The U.S. political system can often feel like an enormous, overwhelming mess. Corruption, red tape, antiquated laws, and worst of all—a total inability to get anything done. Especially amongst younger generations, Americans seem to be discouraged from participating in even the most fundamental political structures. In the 2024 presidential election, only 42% of young...
